VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AORT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AORTArtivion, Inc.
$21.93$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAORTCash Flow

Artivion, Inc. (AORT) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow turned negative at -$12.0M in Q2 2026, with operating cash flow of -$1.3M, as working capital swings and acquisition outflows of $116.7M overshadowed cumulative operating cash flow of $60.2M over ten quarters.

Income StatementBalance SheetCash FlowRatios

AORT Cash Flow Statement

Annual statement

AORT Cash Flow Statement

Artivion, Inc. (AORT) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations39.96M38.13M22.24M18.82M-5.15M-2.58M12.37M15.83M9.88M10.8M19.72M11.44M8.12M16.77M18.99M16.75M20.84M16.57M9.54M9.29M-1.07M-18.52M-16.23M-5.93M-2.11M6.48M10.28M987K1.2M-2.2M4M
Operating CF Margin %-8.64%5.72%5.32%-1.64%-0.86%4.88%5.73%3.76%5.69%10.93%7.84%5.61%11.92%14.42%14%17.86%14.84%9.08%9.81%-1.32%-26.73%-26.01%-9.96%-2.71%7.39%13.33%1.48%1.98%-4.32%10.81%
Operating CF Growth %170.36%71.48%18.12%465.32%-99.34%-120.9%-21.85%60.18%-8.53%-45.22%72.34%40.95%-51.6%-11.68%13.37%-19.61%25.74%73.77%2.64%967.6%94.22%-14.12%-173.53%-181%-132.58%-36.97%941.44%-17.75%154.55%-155%263.64%
Net Income-3.17M9.77M-13.36M-30.69M-19.19M-14.83M-3.46M1.72M-2.84M3.7M10.78M4M7.32M16.17M7.95M7.37M3.94M8.68M32.91M7.2M365K-19.54M-18.75M-32.29M-27.76M9.17M7.82M4.45M6.5M4.7M3.9M
Depreciation & Amortization24.56M22.46M24.2M23.08M22.44M23.98M27.86M18.32M18.09M9.74M8.38M5.86M6.03M5.84M5.63M4.96M3.94M4.26M4.35M4.46M4.84M5.04M5.48M5.51M5.42M4.61M3.22M3.15M3.5M2.7M1.4M
Stock-Based Compensation16.58M24.39M14.24M14.42M12.34M10.71M6.91M8.8M6.33M6.92M6.33M5.09M3.44M3.24M3.16M2.79M2.62M2.43M2.1M2.13M1.62M358K358K00000000
Deferred Taxes-1.15M37K-1.51M-1.39M-1.72M-4.47M4.28M-2.31M-4.49M-1.48M595K3.68M178K617K1.23M1.77M-1.51M5.25M-7K-961K226K3.55M7.19M5.73M-5.57M624K1.66M-970K-1.9M400K0
Other Non-Cash Items26.04M3.64M15.9M29.59M6.91M15.26M3.47M8.68M2.8M2.79M-6.28M718K-324K-7.52M1.31M1.04M7.73M652K-18.29M1.72M2.16M-2.48M10K347K38.01M348K616K1.19M-100K100K200K
Working Capital Changes-22.9M-22.16M-17.24M-16.19M-25.94M-33.23M-26.7M-19.38M-10.01M-10.87M-83K-7.91M-8.52M-1.58M-289K-1.17M4.11M-4.71M-11.52M-5.25M-10.28M-5.45M-10.52M7.9M-12.21M-8.98M-3.03M-6.84M-6.6M-10.1M-1.5M
Change in Receivables-5.58M-7.27M-15.39M-4.05M-13.34M-11.56M9.94M-3.38M-5.91M-7.26M4.14M-3.81M-4.56M-1.64M1.36M-2.23M179K-80.36M-68.24M2.78M-36.31M-29.87M-30.03M00000000
Change in Inventory-20.51M-15.28M-6.14M-14.36M-8.4M-18.38M-24.76M-8.13M2.38M-9.37M-9.46M-2.26M-1.13M193K-1.6M2.44M-1.8M-1.14M-2.92M-454K-600K158K-517K135K-1.43M-2.27M-1.43M-2.88M-3M-900K200K
Change in Payables4.04M2.18M9.5M1.68M-1.96M-1.89M-9.16M251K-8.87M8.73M4.72M-656K-64K572K529K-772K2.38M483K267K842K155K342K342K00000000
Cash from Investing-175.03M-42.04M-28.19M-502K-10.71M5.66M-73.13M-23.94M-6.71M-170.99M-73.85M-4.49M-5.35M10.88M-22.92M-27.72M-10.73M-4.38M-4.34M446K-557K-2.03M457K9.35M6.28M-18.1M-6.63M-3.28M-18.9M-9.6M-4.9M
Capital Expenditures-50.87M-39.04M-11.19M-7.43M-10.71M-13.09M-7.33M-8.07M-5.79M-7.04M-7.42M-4.1M-5.32M-4.34M-3.07M-2.54M-7.53M-1.69M-1.74M-1.21M-1.64M-989K-950K-955K-4.1M-14.33M-9.49M-3.85M-6.7M-5.1M-9.2M
CapEx % of Revenue10.79%8.85%2.88%2.1%3.41%4.38%2.89%2.92%2.2%3.71%4.12%2.81%3.68%3.08%2.33%2.12%6.46%1.51%1.65%1.27%2.02%1.43%1.52%1.6%5.27%16.34%12.31%5.77%11.04%10.02%24.86%
Acquisitions-116.66M00000-59.12M00-163.92M-71.36M-1.35M198K0-17.04M-21.06M048K019K13K12K26K0000015M00
Investments-------------------------------
Other Investing-7.5M-3M-17M6.93M0-249K-6.68M-15.87M-929K-86K4.87M3K-192K-206K-2.81M-547K-797K-831K-46K-190K-105K-208K-56K1.25M-1.43M1.33M43K-452K-700K-4.5M-1.6M
Cash from Financing159.35M13.03M2.2M865K-1.64M-12.22M93.61M-1.49M-2.56M143.25M73.43M-2.81M-6.95M-3.05M-4.71M-2.85M-4.72M707K-2.43M743K-968K22.73M15.55M-8.03M-1.4M1.33M7.78M-4.46M30.5M10.6M1.8M
Debt Issued (Net)148.78M-2.46M-358K-2.77M-2.75M-3.08M94.65M-2.78M-2.79M152.79M73.59M0000-31K-1.54M-1.33M-4.2M-41K-2.76M3.79M-717K-6.25M-2.21M-176K6.37M-738K-12.5M10M1.2M
Equity Issued (Net)11.24M13.07M5.73M-559K-1.79M-1.91M-2M-2.74M-2.1M-1.61M-697K-1.39M-7.07M-2.2M-3.53M-3.06M-5.88M-330K1.77M1.27M418K19.47M19.65M660K809K1.5M1.05M-3.73M42.9M600K600K
Dividends Paid00000000000-3.41M-3.29M-2.97M-1.37M0000-486K-973K-533K000000000
Share Repurchases000-559K-1.79M-1.91M-2M-2.74M-2.1M-1.61M-697K-1.39M-7.07M-1.52M-3.53M-3.06M-5.88M-330K-611K-478K-50K0-54K0-663K0-612K-4.3M-3.4M00
Other Financing-672K2.42M-3.17M4.2M2.91M-7.22M949K4.03M2.33M-7.93M531K1.98M3.41M2.12M187K249K2.69M2.37M002.35M0-3.38M-2.44M00360K0100K00
Net Change in Cash23.84M11.45M-5.48M19.59M-15.66M-6.95M27.66M-7.94M1.48M-16.66M19.05M4.21M-4.27M24.63M-8.7M-13.79M5.38M12.92M2.74M10.33M-2.5M1.92M-184K-4.61M3.07M-10.28M11.35M-6.76M30.5M10.6M1.8M
Free Cash Flow-10.91M-911K11.05M11.39M-15.87M-15.68M5.04M7.75M4.09M3.76M12.29M7.34M2.8M12.43M15.92M14.21M13.3M14.88M7.8M8.09M-2.71M-19.51M-17.18M-6.89M-6.21M-7.85M788K-2.87M-5.5M-7.3M-5.2M
FCF Margin %-2.31%-0.21%2.84%3.22%-5.06%-5.25%1.99%2.81%1.56%1.98%6.82%5.03%1.93%8.83%12.09%11.88%11.41%13.33%7.42%8.53%-3.34%-28.15%-27.53%-11.57%-7.98%-8.95%1.02%-4.3%-9.06%-14.34%-14.05%
FCF Growth %-242.33%-108.25%-3.05%171.81%-1.22%-410.97%-35%89.38%8.85%-69.4%67.53%162.29%-77.5%-21.9%12.01%6.82%-10.6%90.82%-3.54%398.01%86.09%-13.57%-149.4%-10.88%20.88%-1096.19%127.49%47.89%24.66%-40.38%-940%
FCF per Share-0.22-0.020.270.28-0.40-0.400.130.200.110.110.370.260.100.450.580.510.470.530.280.30-0.11-0.81-0.75-0.35-0.32-0.400.04-0.15-0.30-0.49-0.35
FCF Conversion (FCF/Net Income)3.45x3.90x-1.66x-0.61x0.27x0.17x-0.74x9.20x-2.60x2.92x1.83x2.86x1.11x1.04x2.39x2.27x5.28x1.91x0.29x1.29x-2.93x0.95x0.87x0.18x0.08x0.71x1.31x0.22x0.18x-0.47x1.03x
Interest Paid0000000000000000000000000000000
Taxes Paid0000000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Regulatory delays for JOTEC portfolio

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Earnings Quality Masked by Volatility

Operating cash flow swung from -$17.0M in Q1 2025 to $20.5M in Q3 2025, while net income remained near breakeven, indicating significant non-cash adjustments and working capital swings, per recent filings.

The OCF/NI ratio is highly erratic, ranging from -5.01 to 33.57, suggesting that net income is a poor proxy for cash generation. In Q2 2026, net income was -$13.5M but OCF was only -$1.3M, implying large non-cash charges like D&A and SBC. This divergence warrants close monitoring of accruals and working capital management.

FCF Volatility Masks Underlying Growth

Free cash flow swung from -$20.6M in Q1 2025 to $15.9M in Q3 2025, with Q2 2026 at -$12.0M, reflecting lumpy capex and working capital, as reported in quarterly statements.

FCF margins have been inconsistent, ranging from -20.8% to 14.0%, with no clear upward trend. The TTM FCF is negative, indicating that the company is not yet self-funding its growth. However, the revenue growth of 13.6% TTM suggests that investments are being made to capture market share, which may translate into positive FCF if operating leverage materializes.

Capital Intensity Spikes on Strategic Investments

CapEx surged to $27.5M in Q4 2025 (23.7% of revenue) from $3.3M in Q2 2025, indicating a deliberate investment phase, based on reported figures.

The elevated capex in Q4 2025 and Q2 2026 (8.5% of revenue) suggests investments in manufacturing capacity or regulatory infrastructure, likely tied to the JOTEC portfolio. While this pressures near-term FCF, it may be necessary to support future growth. Investors should monitor whether these investments yield higher revenue and margins.

Working Capital Swings Drive Cash Flow Volatility

Working capital changes ranged from -$26.8M in Q1 2025 to +$3.2M in Q3 2025, with a -$9.2M drag in Q2 2026, indicating significant variability in collections and inventory, per financial statements.

The large negative working capital changes in several quarters suggest that the company is building inventory or facing slower collections, possibly due to consignment stock or international expansion. This volatility is a key driver of the erratic OCF and FCF. Effective working capital management will be crucial to stabilize cash flow.

Acquisition-Driven Cash Deployment

Cash outflows for acquisitions reached $116.7M in Q2 2026, while dividends and buybacks were nil, indicating a focus on inorganic growth, as disclosed in cash flow statements.

The significant acquisition spend in Q2 2026, likely related to JOTEC or other strategic assets, underscores management's commitment to expanding the product portfolio. With no dividends or buybacks, all cash is being reinvested. This strategy could enhance long-term value if the acquired assets generate expected synergies, but it also increases integration risk.

Cumulative Earnings vs Cash: A Persistent Gap

Over the last ten quarters, cumulative net income is approximately -$15.3M, while cumulative operating cash flow is +$60.2M, indicating that cash generation has outpaced reported earnings, based on quarterly data.

The positive cumulative OCF despite negative net income suggests that non-cash charges like D&A and SBC are significant, and that working capital has been a source of cash in some periods. This divergence implies that the company's cash-generative capacity may be stronger than earnings suggest, but it also highlights the impact of heavy investment and acquisition-related costs.

What Could Invalidate the Base Case

The sustained gap between 13.6% TTM revenue growth and 6.1% operating margin suggests that heavy investment may not yield expected operating leverage, as per the latest financials.

If the elevated capex and acquisition spend do not translate into improved margins and positive FCF, the company may face prolonged cash burn. Additionally, the reliance on acquisitions for growth introduces integration risk, and any delays in regulatory approvals for the JOTEC portfolio could further pressure cash flow. Investors should monitor whether the company can achieve positive FCF without additional external financing.

AORT — Frequently Asked Questions

Quick answers to the most common questions about buying AORT stock.

How much cash does Artivion, Inc. (AORT) generate from operations?

Artivion, Inc. (AORT) generated $38.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Artivion, Inc.'s free cash flow?

Artivion, Inc. (AORT) reported negative free cash flow of $0.9M in 2025, indicating capital requirements exceeded cash from operations.

What is Artivion, Inc.'s capital expenditure (CapEx)?

Artivion, Inc. (AORT) spent $39.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.